Podcast

Alexander Rothman, PhD, on the Effects of IL-1β Inhibition With Canakinumab on BP and Hypertension

03/20/2020

 

In this podcast, Alexander Rothman, MD, PhD, discusses his team's latest analysis of CANTOS, which evaluated whether interleukin-1β inhibition would reduce blood pressure, prevent incident hypertension, and modify relationships between hypertension and cardiovascular events.

Additional Resources:

  • Rothman AMK, MacFadyen J, Thuren T, et al. Effects of interleukin-1β inhibition on blood pressure, incident hypertension, and residual inflammatory risk: a secondary analysis of CANTOS. Hypertension. 2020;75(2):477-482. https://doi.org/10.1161/HYPERTENSIONAHA.119.13642. 
  • Ridker PM, Everett BM, Thuren T, et al; CANTOS Trial Group. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377(12):1119-1131. https://doi.org/10.1056/nejmoa1707914. 

 

Alexander Rothman, MD, PhD, is a Wellcome Trust Clinical Research Career Development Fellow and honorary consultant cardiologist at the University of Sheffield and Sheffield Teaching Hospital NHS Trust in the United Kingdom.

Related Content

Stress and Burnout
Stress and Burnout
Seth Gross, MD, On Resuming Endoscopy Safely in the Age of COVID-19
06/01/2020
He discusses how gastroenterologists can resume semi-elective and elective endoscopies by following key guidelines to protect patients and staff against COVID-19.
06/01/2020
HIV Prevention
HIV Prevention
Daniel R. Kuritzkes, MD, on HIV Resistance After PrEP
10/14/2021
He talks about HIV resistance in the context of pre-exposure prophylaxis use, how common it is, and how PrEP might influence subsequent therapies.
10/14/2021
Stress and Burnout
Stress and Burnout
Bruce Y. Lee, MD, on the FDA’s Emergency Authorization of Remdesivir
05/28/2020
In this podcast, Dr Lee discusses available data on the use of remdesivir for the treatment of severe COVID-19, and how the FDA's emergency authorization of remdesivir will impact the care of hospitalized...
05/28/2020
Vascular Disease
Vascular Disease
Klaus Ley, MD, on Inflammation in, Vaccination for Atherosclerosis
01/28/2019
Dr Klaus Ley, from the La Jolla Institute for Immunology, talks about his research on inflammation in atherosclerosis, as well as a potential vaccine against atherosclerosis.
01/28/2019
Rheumatology
Rheumatology
Mary O'Connor, MD, on the "Vicious Cycle" of Joint Pain and Obesity
05/08/2017
Mary O'Connor, MD, irector of the Center for Musculoskeletal Care at Yale School of Medicine and Yale New Haven Health, discuses the "Vicious Cycle" of joint pain.
05/08/2017